
AngioDynamics Earnings Put Med Tech Growth in Focus
AngioDynamics posted 6.9% sales growth and stronger Med Tech momentum while reiterating fiscal 2027 guidance ahead of a CEO transition.

AngioDynamics posted 6.9% sales growth and stronger Med Tech momentum while reiterating fiscal 2027 guidance ahead of a CEO transition.

Delta reports September-quarter results today, with investors focused on mid-teens revenue growth, margins, fuel costs and full-year guidance.

Firmus withdrew its planned ASX IPO and will pursue private capital, sharpening scrutiny of AI infrastructure valuations and funding needs.

Airtel Money enters conditional London trading at £1.96 a share, implying a £5.3 billion valuation before full admission on October 14.

Moderna joins the Nasdaq-100 before the October 9 market open, replacing Warner Bros. Discovery and expanding its institutional index exposure.

The American Express fine totals $350 million after regulators cited AML control failures tied to $13 billion in suspected laundering activity.

Green AI Cloud’s proposed Pioneer merger carries a $300 million pre-money equity value and targets a Nasdaq listing in the second quarter of 2027.
Samsung projected 107.4 trillion won in third-quarter operating profit and 195 trillion won in sales, pending its detailed earnings release.

HubSpot layoffs will eliminate nearly 660 jobs as the software company flattens management and reorganizes product teams around AI-driven outcomes.

SOS stock faces pressure after half-year revenue fell 45.5% to $48.8 million while the net loss widened to $34.5 million and margins weakened.